Myeloma Investment Fund invests in Nammi Therapeutics, Inc.'s Series B financing
Client(s) Myeloma Investment Fund
Jones Day advised Myeloma Investment Fund in $1 million investment in Nammi Therapeutics, Inc.'s Series B financing.
Client(s) Myeloma Investment Fund
Jones Day advised Myeloma Investment Fund in $1 million investment in Nammi Therapeutics, Inc.'s Series B financing.